The analysis looked at patients who were newly taking highly popular GLP-1 medicines — which mimic the GLP-1 hormone and reduce appetite — from Eli Lilly and Novo Nordisk, and compared them to similar patients who were not taking the drugs.
Real-world analysis finds better outcomes and lower medical spending, but current prices limit the full economic value WOONSOCKET, R.I., Nov. 15, 2026 /PRNewswire/ -- CVS Health today released new research grounded in real-world data that puts numbers behind a central question facing...
Ready. Set. Shop!
Spinning off its drugstores won’t quiet CVS’s critics, but it could leave shareholders with a more valuable company.
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses. Shareholders should contact the...
Seven Stevie® Awards honor innovations across enterprise AI portfolio, including clinical operations, disaster response and workforce development WOONSOCKET, R.I., Nov. 11, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) is being recognized with seven Stevie® Awards for technology and...
CVS Health Chief Executive Officer and Chairman David Joyner says no offers have been received yet for its retail pharmacy business which is being spun off in the first half of next year. The company's Aetna insurance unit and Caremark pharmacy benefits division are staying together. Joyner talks…
WOONSOCKET, R.I., Nov. 9, 2026 /PRNewswire/ -- CVS Pharmacy®, the retail division of CVS Health® (NYSE: CVS), is helping shoppers take on the holidays with gifts, décor, stocking stuffers, personalized photo favorites and festive essentials for everyone on their list and every budget....
